Search results
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 6 days agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 3 days ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 3 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 6 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 2 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 7 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 3 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...